Highlights of Nursing Role in Oncology & Hematology - Chapter 6

Join us for an engaging workshop designed to empower oncology team members with Navigating PARP Inhibitors in Ovarian Cancer. This interactive session will cover essential updates, best practices, and innovative approaches to enhance patient care.

19:00

Opening​

Khaled Al Qawasmeh

19:05

PARP inhibitor in review

Emad Anwar

19:25

Mastering PARPi Treatment: Essential Knowledge on Adverse Events and Dosing for Oncology Nurses

Lina Wahba

19:45

Discussion

19:55

Summary & Closing

Khaled Al Qawasmeh

Time

Topic

Presenter

19:30 - 19:35

Opening Remarks

Khaled Al Qawasmeh

19:35 - 21:30

Moderator

Dr. Nouri Benini

19:35 - 20:00

Optimizing treatment approaches on respectable NSCLSC

Dr. Husam Marashi

20:00 - 20:30

Improving Survival outcome in unresectable stage III NSCLC

Dr. Emad Anwar

20:30 - 21:30

Real life clinical practise
(case discussions)

Dr. Emad Anwar

Dr. Edward Black

Dr. Hussam Marashi

Faculty

Khaled Al Qawasmeh

Speaker

Khaled Al Qawasmeh

President

Emirates Oncology Nursing Society

United Arab Emirates

Emad Anwar

Speaker

Emad Anwar

Consultant Oncologist

Tawam Hospital

Abu Dhabi, UAE

Lina Wahba

Guest Expert

Lina Wahba

Head of clinical pharmacy team and the principal oncology clinical pharmacist at the adult oncology unit

Tawam Hospital

Abu Dhabi, UAE